Kayne Anderson Rudnick Investment Management
KITE

Kayne Anderson Rudnick Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,252
Closed -$1.89M – 345
2017
Q2 		$1.89M Sell
18,252
-778
-4% -$63.5K 0.02% 258
2017
Q1 		$1.49M Sell
19,030
-460
-2% -$28.4K 0.02% 274
2016
Q4 		$874K Sell
19,490
-165
-0.8% -$8.09K 0.01% 293
2016
Q3 		$1.1M Buy
+19,655
New +$1.1M 0.01% 281

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's KITE Position: Q3 2017 in Review

Kayne Anderson Rudnick Investment Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 18,252 shares — an estimated $1.89M sold.

Kayne Anderson Rudnick Investment Management first reported a position in KITE in Q3 2016 and held it in 4 quarters. The position peaked at $1.89M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Kayne Anderson Rudnick Investment Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 18,252 Kite Pharma, Inc. shares in Q3 2017, an estimated $1.89M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 4 quarters.
  • Kayne Anderson Rudnick Investment Management's Kite Pharma, Inc. position peaked at $1.89M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2017, filed 7 Nov 2017.